ADVERTISEMENT
Search

May 2025

Pharmacy Today logo
Volume 31, Issue 5

Archives   Download TOC  

Current Issue

May 2025 cover

Download  

ADVERTISEMENT
 

Practice & Trends

Danziten and Tasigna are not interchangeable although both contain nilotinib

Medication Safety

Danziten and Tasigna are not interchangeable although both contain nilotinib

In November 2024, Azurity announced the approval of Danziten (nilotinib), indicated for adults with newly diagnosed Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML) in the chronic phase (CP) and adults with CP and accelerated phase (AP) Ph+ CML resistant to or intolerant to prior therapy that included imatinib.

Institute for Safe Medication Practice, Plymouth Meeting, PA

RSS
News Roundup
Bulletin Today

Bulletin Today

News Roundup

Dismissing patient, family, and caregiver concerns is the biggest threat to patient safety, according to ECRI. The organization said that time and resource constraints are making it increasingly difficult for health care providers to address patient concerns.

APhA staff

RSS

Drugs & Diseases

RSS

Health Systems

AHA, ACC release new guidelines on acute coronary syndrome
Health Systems

Cardiology

AHA, ACC release new guidelines on acute coronary syndrome

The field of cardiology is evolving rapidly, which means guidelines must keep up. In early 2025, the American Heart Association, along with the American College of Cardiology, released an updated clinical practice guideline to improve care for patients experiencing acute coronary syndrome (ACS).

Loren Bonner

Trending Topics
Health Systems

Inpatient Insights

Trending Topics

Pseudomonas aeruginosa bloodstream infections remain a major cause of mortality in ICUs, posing many treatment uncertainties. Although several antibiotics have been used to treat these infections, comparative effectiveness is unclear.

APhA Staff

RSS

CPE

New guidelines for clinical management of acne
CPE

CPE

New guidelines for clinical management of acne

Acne vulgaris is a prevalent dermatological condition that significantly affects individuals’ quality of life and poses substantial challenges in clinical management.

Jamie L. McConaha, PharmD, NCTTP, BCACP, CDCES; Lucia Massaro, PharmD Candidate 2025; Morgan Newton, PharmD Candidate 2025

RSS

In this Issue

RSS
ADVERTISEMENT